75F40125F19007↗
Deloitte Consulting LLP received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $1.75M obligated so far for special studies/analysis- regulatory. Its period of performance ended 2026-01-30.
Key facts · data as of Oct 26, 2026
- Recipient
- Deloitte Consulting LLP
- Awarding agency
- Food and Drug Administration (Department of Health and Human Services)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Obligated to date
- $1.75M
- Potential value
- $1.75M
- Ends
- 2026-01-30
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 75F40125F19007, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75F40125F19007_7524_75F40122A00018_7524
Deloitte Consulting LLP: all federal awards · Department of Health and Human Services: spending · Fda Office of Acq Grant Svcs: what it buys
DRUG LABELING INITIATIVE BPA
What it is
- Product or service
- Special Studies/Analysis- Regulatory (PSC B528)
- Industry
- All Other Professional, Scientific, and Technical Services (NAICS 541990)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Competition
- Not competed under simplified acquisition · 1 offer received
- Pricing
- Firm fixed price
- How it was bought
- Blanket purchase agreement (BPA) · under 75F40122A00018
- Where the work is
- Arlington, VA · district VA-08
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
1 subaward totaling $60.9K (3.5% of what was obligated), as Deloitte Consulting LLP reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Shabas Solutions LLC | $60.9K | 1 | VA | 2025-04-17 | 2025-04-17 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2025-04-17 | Shabas Solutions LLC | $60.9K | DRUG LABELING INITIATIVE BPA |
Every action
1 action since 2025-01-17. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-01-17 | 0 | $1.75M | DRUG LABELING INITIATIVE BPA |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗